"The U.S. Food and Drug Administration recently approved Oralair to treat allergic rhinitis (hay fever) with or without conjunctivitis (eye inflammation) that is induced by certain grass pollens in people ages 10 through 65 years. Oralair is the f"...
BEPREVE® (bepotastine besilate) Ophthalmic Solution 1.5% is a histamine H1 receptor antagonist indicated for the treatment of itching associated with signs and symptoms of allergic conjunctivitis.
Dosage Forms And Strengths
Topical ophthalmic solution containing bepotastine besilate 1.5%
Storage And Handling
BEPREVE (bepotastine besilate ophthalmic solution) 1.5% is supplied in a white low density polyethylene plastic squeeze bottle with a white controlled dropper tip and a white polypropylene cap in the following size:
5 mL (NDC 67425-007-50)
10 mL (NDC 67425-007-75)
Store at 15° – 25°C (59° – 77°F).
Manufactured for: ISTA Pharmaceuticals®, Inc. Irvine, CA 92618. By: Bausch & Lomb Incorporated Tampa, FL 33637. Revised: 06/2012
Last reviewed on RxList: 7/5/2012
This monograph has been modified to include the generic and brand name in many instances.
Additional Bepreve Information
Bepreve - User Reviews
Bepreve User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Allergies & Asthma
Improve treatments & prevent attacks.